FAQS
|
|
Definition
of the disease
MALARIA
is a life-threatening parasitic disease transmitted
by mosquitoes. It was once thought that the disease
came from fetid marshes, hence the name ‘mal aria,’
(bad air). In 1880, scientists discovered the real cause of malaria—a one-cell
parasite called plasmodium. Later they discovered that
the parasite is transmitted from person to person through
the bite of a female Anopheles mosquito, which requires
blood to nurture her eggs.
|
|
Transmission
There
are four types of human malaria Plasmodium
vivax, P. malariae, P. ovale and P.
falciparum. P. vivax and P. falciparum
are the most common and falciparum the most deadly
type of malaria infection. Plasmodium falciparum
malaria is most common in Africa, south of the Sahara,
accounting in large part for the extremely high mortality
in this region. There are also worrying indications of the spread of P.
falciparum malaria into new regions of the world
and its reappearance in areas where it had been eliminated.
The malaria parasite enters the human host
when an infected Anopheles mosquito takes a blood meal.
Inside the human host, the parasite undergoes a series
of changes as part of its complex life-cycle. Its various
stages allow plasmodia to evade the immune system, infect
the liver and red blood cells, and finally develop into
a form that is able to infect a mosquito again when
it bites an infected person. Inside the mosquito, the
parasite undergoes more changes until it reaches the
stage where it can again infect a human host when the
mosquito takes her next blood meal, 10 to 14 or more
days later.
|
|
Symptoms
Malaria symptoms
appear about 9 to 14 days after the infectious mosquito
bite, although this varies with different plasmodium
species. Typically, malaria produces fever, headache,
vomiting and other flu-like symptoms. If drugs are not
available for treatment or the parasites are resistant
to them, the infection can progress rapidly to become
life-threatening. Malaria can kill by infecting and
destroying red blood cells (anaemia) and by clogging
the capillaries that carry blood to the brain (cerebral
malaria) or other vital organs.
|
|
Prevalence
Today
approximately 40% of the world's populationmostly
those living in the world's poorest countriesis
at risk of malaria. The disease was once more widespread
but it was successfully eliminated from many countries with temperate
climates during the mid 20th century. Today malaria
is found throughout the tropical and sub-tropical regions
of the world and causes more than 300 million acute
illnesses and at least one million deaths annually.
Ninety per cent of deaths due to malaria
occur in Africa, south of the Saharamostly among
young children. Malaria kills an African child every
30 seconds. Malaria is Africa's leading cause of under-five
mortality (20%) and constitutes 10% of the continent's
overall disease burden. It accounts for 40% of public
health expenditure, 30-50% of inpatient admissions,
and up to 50% of outpatient visits in areas with high
malaria transmission. Many children who survive an episode
of severe malaria may suffer from learning impairments
or brain damage. Pregnant women and their unborn children
are also particularly vulnerable to malaria, which is
a major cause of perinatal mortality, low birth weight
and maternal anaemia
|
|
Treatment
and Drug Resistance
One of the greatest challenges facing Africa
in the fight against malaria is drug resistance. Resistance
to chloroquine, the cheapest and most widely used antimalarial,
is common throughout Africa (particularly in southern
and eastern parts of the continent). Resistance to sulfadoxine-pyrimethamine
(SP), often seen as the first and least expensive alternative
to chloroquine, is also increasing in east and southern
Africa. As a result of these trends, many countries
are having to change their treatment policies and use
drugs which are more expensive, including combinations
of drugs, which it is hoped will slow the development
of resistance.
|
Epidemics
EPIDEMICS
occur when malaria attacks vulnerable populations with
little or no immunity. In such situations, people of
all age groups are at risk of death or severe disease.
The populations most at risk of epidemics are those
living in highlands, arid and desert-fringe zones, as
well as those living in areas where successful control
measures have not been consolidated or maintained.
There are two categories of factors which may precipitate
a malaria epidemic: natural (climatic variations, natural
disasters), and man-made (conflict and war, agricultural
projects, dams, mining, logging). Many of these factors
modify the physical environment in some way, leading
to an increase in the capacity of mosquitoes to transmit
malaria. Some factors also result in massive population
movements that expose non-immune populations to malaria
infection.
Epidemics of Plasmodium falciparum malaria, the most
severe form of the disease, can be devastating if not
controlled quickly. It is difficult to predict when
and where such epidemics are going to occur because
malaria epidemics tend to occur in populations not normally
exposed to the disease, or who are exposed for only
a short part of the year. As a result local health services
are usually unprepared to predict, detect and control
such epidemics in time, resulting in severe cases and
high death rates.
|
Economic
Effects and Challenges
Malaria
has been estimated to cost Africa more than US$12 billion
every year in lost GDP, even though it could be controlled
for a fraction of that sum. Economists believe that malaria
is responsible for a growth penalty of up
to 1.3% per year in some African countries. Over the years
this has severely restrained the economic growth of the
entire region. Malaria also has a direct impact on Africa's
human resources. Not only does malaria result in lost
life and lost productivity due to illness and premature
death, but malaria also hampers children's schooling and
social development through both absenteeism and permanent
neurological and other damage associated with severe episodes
of the disease.
Malaria, together with HIV/AIDS and TB, is
one of the major public health challenges undermining
development in the poorest countries in the world. Malaria
parasites have become resistant to one drug after another
and many insecticides are no longer useful against the
mosquitoes which transmit the disease. Years of vaccine
research have produced few hopeful candidates and although
scientists are redoubling the search, an effective vaccine
is at best years away. There is still no magic bullet
for malaria and there is doubt that such a single solution
will ever exist.
|
Roll
Back Malaria
ROLL
BACK MALARIA is promoting four main strategies to pursue
its goal of halving the world's burden of malaria by 2010.
The strategies are evidence-based (shown to be effective),
outcome-focussed and cost-effective. Effective
low-cost strategies are already available for the treatment,
prevention and control of malaria. The Roll Back Malaria
global partnership is vigorously promoting them in Africa
and other malaria-endemic regions of the world. If countries can apply these and other
measures on a wide scale, then the burden of malaria will
be significantly reduced.
- Prompt access to treatment with effective up-to-date medicines
saves lives
- Insecticide-treated mosquito nets (ITNs) reduce malaria transmission and child deaths.
- Prevention and control of malaria in pregnant women results in improvement in maternal health, infant health and survival
- Malaria
epidemic and emergency response
|
|
Source:
WHO
|
|
|